THRX, Theravance, Inc.
PWRM, Power 3 Medical Products Inc, PWRM.OB
SPNG, SpongeTech Delivery Systems Inc, SPNG.OB
DrStockPick Watch List!
DrStockPick.com Watch List! for Monday September 14, 2009
My Picks for Monday September 14, 2009 are:
SPNG, SpongeTech Delivery Systems Inc, SPNG.OB
SPNG is a company which designs, produces and markets innovative, cost-effective, and environmentally sensitive packaging and product delivery solutions through its exclusive patented packaging technology.
SPNG plans to apply for a NASDAQ listing. Its Board of Directors has unanimously approved a reverse split of SpongeTech��s issued and outstanding capital stock at a 1-for-100 split ratio. The reverse stock split demonstrates its commitment to establishing SpongeTech as a world-class company whose capital structure, operations and infrastructure all match the impressive sales growth SPNG are achieving.
SPNG invested $4 million in GetFugu, Inc., a technology company that focuses on developing mobile search tools. GetFugu (using its innovative mobile search platform) will point SPNG consumers to the nearest retail location that carries SPNG products based on the GPS functionality available in most mobile phones and/or be automatically connected to SpongeTech�s corporate Internet e-commerce portal to buy SPNG products on-line.
SPNG Takes Steps to Reduce Authorized Common Shares to 300 Million to provide clarity with respect to SPNG�s capital structure and enhance its stock�s desirability for both current and prospective investors.
PWRM, Power 3 Medical Products Inc, PWRM.OB
PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.
PWRM�s NuroPro PD test was developed to help clinicians distinguish patients with Parkinson�s disease from �normal� individuals and patients with other neurological disorders. The NuroPro PD test, developed by Power3, utilizes a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability that a patient has Parkinson�s disease.
PWRM and Transgenomic, Inc. announced recently the advance on-line publication of a clinical research paper entitled �Abnormal Serum Concentrations of Proteins in Parkinson�s Disease� in the scientific journal Biochemical and Biophysical Research Communications. The study demonstrates the usefulness of a protein biomarker panel to distinguish Parkinson�s disease patients from age-matched normal controls independent of the severity of symptoms, using clinical blood serum samples.
THRX, Theravance, Inc.
THRX is a biopharmaceutical company with a pipeline of internally discovered product candidates. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.
The U.S. Food and Drug Administration has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. VIBATIV is a bactericidal, once-daily injectable lipoglycopeptide antibiotic discovered by THRX.
Add THRX, SPNG and PWRM to your Watch List!, do your homework, and like always BE READY for the ACTION!
No comments:
Post a Comment